NRXP has entered a transformative partnership with Alvogen Pharmaceuticals for the development and marketing of NRX-101.

The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment ...

Researchers have identified a second dopamine-driven "clock" in the brain that works alongside the biological 24-hour cycle, ...

People with bipolar disorder face stigma and treatment challenges. Despite these barriers, it's possible to live a full and ...

These two disorders share many features, making proper diagnosis a challenge. Treatment providers must be aware that some ...

New research suggests that mood swings in bipolar disorder are regulated by two clocks: the body’s 24-hour circadian rhythm ...

Mental health forms a crucial component of overall well-being, yet many conditions remain undiagnosed or misunderstood.

People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Bipolar disorder is a complex psychiatric condition that involves mood episodes (mania or depression) that affect mental state, quality of life and the ability to function 1. The heritability of ...

Harael (Harahel) is the angel of Capricorns, born between 11th and 15th January. 😇 As the Guardian Angel of intellectual ...

Meanwhile, researchers are focusing on one particularly stringent diet regimen as a candidate for alleviating serious mental illnesses such as bipolar disorder, schizophrenia and major depression.